User contributions
From 2007.igem.org
(Latest | Earliest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 22:58, 24 October 2007 (diff | hist) Security device
- 22:57, 24 October 2007 (diff | hist) N Security device
- 22:56, 24 October 2007 (diff | hist) Paris/Perspectives (→Security device)
- 22:56, 24 October 2007 (diff | hist) Paris/Perspectives (→Security device)
- 22:55, 24 October 2007 (diff | hist) Paris/Perspectives (→Secured device)
- 22:55, 24 October 2007 (diff | hist) Paris/Perspectives (→Triglyceride synthesis)
- 22:54, 24 October 2007 (diff | hist) See here (top)
- 22:54, 24 October 2007 (diff | hist) See here
- 22:52, 24 October 2007 (diff | hist) See here
- 22:48, 24 October 2007 (diff | hist) See here
- 22:48, 24 October 2007 (diff | hist) See here
- 22:45, 24 October 2007 (diff | hist) Paris/Perspectives (→Decoupling reproduction faculty and transgene expression)
- 22:45, 24 October 2007 (diff | hist) Paris/Perspectives (→Decoupling reproduction faculty and transgene expression)
- 22:44, 24 October 2007 (diff | hist) Paris/Perspectives (→Decoupling reproduction faculty and transgene expression)
- 22:44, 24 October 2007 (diff | hist) Paris/Perspectives (→Decoupling reproduction faculty and transgene expression)
- 22:43, 24 October 2007 (diff | hist) Paris/Perspectives (→Applications)
- 22:38, 24 October 2007 (diff | hist) Paris/Perspectives (→Secured device)
- 22:37, 24 October 2007 (diff | hist) Paris/Perspectives (→Triglyceride synthesis)
- 22:37, 24 October 2007 (diff | hist) Paris/Perspectives (→Others biomedical applications)
- 22:37, 24 October 2007 (diff | hist) Paris/Perspectives (→Others biomedical applications)
(Latest | Earliest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)